Perpetual »

Keros Therapeutics shares owned by Perpetual

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Perpetual from 13F filings

Historical chart of Perpetual investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Perpetual consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Perpetual

Quarter filed Position value Share count Share price at filing
2024-03-31 $443k 6.7k 66.20

More positions owned by Perpetual

Linde SHS (LIN)
CRH Ord (CRH)
Microsoft Corporation (MSFT)
Itau Unibanco Hldg S A Spon Adr Rep Pfd (ITUB)
Anthem (ELV)
Accenture Plc Ireland Shs Class A (ACN)
MercadoLibre (MELI)
Philip Morris International (PM)
Globant S A (GLOB)
UnitedHealth (UNH)
Sempra Energy (SRE)
Intercontinental Exchange (ICE)
Alphabet Cap Stk Cl A (GOOGL)
Gxo Logistics Incorporated Common Stock (GXO)
Henry Schein (HSIC)

View all positions for Perpetual

Top funds holding Keros Therapeutics

FMR
BlackRock
Vanguard Group
OrbiMed Advisors
Braidwell
Darwin Global Management
T. Rowe Price Associates
Citadel Advisors
ADAR1 Capital Management
Candriam Luxembourg S.C.A.
Leucadia National Corporation
Franklin Resources
Geode Capital Management
Eventide Asset Management
Millennium Management

View all funds holding Keros Therapeutics